HIGHLIGHTS
- who: Marija Petrovic et al. from the School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland have published the research work: Synthesis, Formulation and Characterization of Immunotherapeutic Glycosylated Dendrimer/cGAMP Complexes for CD206 Targeted Delivery to M2 Macrophages in Cold Tumors, in the Journal: Pharmaceutics 2022, 1883 of 13/07/2022
- what: As it was shown that eukaryotic cyclic dinucleotide (CDN)-20 30 Cyclic GMP-AMP (20 30 cGAMP)-showed a higher affinity towards the STING pathway compared to prokaryotic 30 30 cGAMP, for the purpose of this work, 20 30 cGAMP was the ligand . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.